2021-04-07 19:21:18 | Your Thursday Briefing – The New York Times

Story by: Melina Delkic The New York Times World News

We’re covering losses for President Moon Jae-in’s party in Seoul and Busan and the latest guidance on the AstraZeneca vaccine.

Analysis: Mr. Moon’s approval ratings have been in a tailspin, amid North Korea diplomacy stumbles, a housing scandal and frustration with prolonged coronavirus restrictions. Many voters planned to support opposition candidates not because of their platforms, but to “pass judgment on the Moon Jae-in government,” surveys found.

Britain said on Wednesday that it would offer alternatives to the AstraZeneca vaccine for adults under 30 as European regulators described a “possible link” with rare blood clots.

It was a setback for the world’s most widely used vaccine and a blow to more than 100 countries relying on it, particularly the global south. Europe’s medical regulator stopped short of advising that the use of the vaccine be curbed in the bloc.

READ  2021-03-12 21:13:34 | WHO Grants Emergency Authorization to Johnson & Johnson Vaccine

U.K. and European regulators both said that it was possible that a small number of blood clots were linked to the vaccine, but that more investigation was needed. European regulators described the cases as a serious but “very rare” side effect, reiterating that the benefits outweighed the risk, but said that health professionals and recipients should be cautious about symptoms. Officials have not concluded that age or gender were specific risks.

Context: Britain had been a holdout in Europe, never wavering in its use of the AstraZeneca vaccine. But evidence mounted that very small numbers of Britons had the clots.

Here are the latest updates and maps of the pandemic.

In other developments:

Private investigators led by a former military operative. A mysterious USB stick filled with private emails. Checking in on workers on medical leave. Former Ikea France leaders are accused of using an extensive system of espionage, which court documents say stretches back to 2002. The case has reopened questions about data privacy at work and the tensions between employers and unions in France, while riveting the nation.

In 1971, shortly before Bruce Lee would achieve international acclaim in action films, the actor pitched a show about a Chinese martial artist called “The Warrior.” Studios turned it down. Lee said it was because executives didn’t think an Asian lead could attract American viewership.

A year later, a different television show, “Kung Fu,” helped introduce many Western audiences to martial arts — but the producers passed over Lee for a starring role. They instead chose David Carradine, a white actor with no prior knowledge of martial arts, to play a half-Chinese Shaolin monk in the Wild West.

Now the CW network is rebooting “Kung Fu,” with a predominantly Asian-American cast. The show “is attempting to right some of the wrongs of the original series,” as Max Gao writes in The Times.

Set in modern-day San Francisco, the drama is about a young Chinese-American woman, played by Olivia Liang, who fights crime. “It’s exciting that we get to reclaim it,” Liang told The Times, “and to say, ‘Hopefully, we’re doing it justice, the way it should have always been done.’”

Story continues…

Source References: The New York Times World News
READ  2021-03-24 03:23:05 | Your Wednesday Briefing - The New York Times

Leave a Reply